Current Radiopharmaceuticals
Volume 15, 4 Issues, 2022
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
Contents
Current Radiopharmaceuticals , Volume 4 - Number 2
Radiotracers Based on Technetium-94m
, 4(2): 90 - 101Katherine Gagnon, Steve McQuarrie, Doug Abrams, Alexander J. McEwan and Frank Wuest
DOI: 10.2174/1874471011104020090
The Unrealized Potential of 34mCl for Radiopharmaceutical Research with PET
, 4(2): 102 - 108Jonathan W. Engle, Todd E. Barnhart, Gregory W. Severin and Robert J. Nickles
DOI: 10.2174/1874471011104020102
Recent Advances in Copper Radiopharmaceuticals
, 4(2): 109 - 121Guiyang Hao, Ajay N. Singh, Orhan K. Oz and Xiankai Sun
DOI: 10.2174/1874471011104020109
PET Tracers Based on 86Y
, 4(2): 122 - 130Jinming Huang, Liyang Cui, Fan Wang and Zhaofei Liu
DOI: 10.2174/1874471011104020122
PET Tracers Based on Zirconium-89
, 4(2): 131 - 139Yin Zhang, Hao Hong and Weibo Cai
DOI: 10.2174/1874471011104020131
Nanoradiopharmaceuticals: Is that the Future for Nuclear Medicine?
, 4(2): 140 - 143Ralph Santos-Oliveira
DOI: 10.2174/1874471011104020140
An Optimised Radiolabel Procedure to Prepare 99mTc-Colloidal Rhenium Sulphide to Improve Radiochemical Purity
, 4(2): 144 - 149Benoit Hosten, Romain Roche, Emmanuelle Barre, Julien Fouque, Yvan Mouraeff, Agnes Dumont, Catherine LE Meur, Helene Garrigue, Sabrina Hassoun, Valerie Nataf, Corinne Smadja, Virginie de Beco, Karine Felice and Nathalie Rizzo-Padoin
DOI: 10.2174/1874471011104020144
Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model
, 4(2): 150 - 160Haladhar D. Sarma, Tapas Das, Sharmila Banerjee, Meera Venkatesh, Pandit B. Vidyasagar and Kaushala P. Mishra
DOI: 10.2174/1874471011104020150
Comparison of Three Radiochemical Purity Control Methods of 99mTc-macroaggregated Albumin
, 4(2): 161 - 166Francois Hallouard, Adeline Paul and Marc Fraysse
DOI: 10.2174/1874471011104020161
Relative Hypermetabolism of Vermis Cerebelli in Traumatic Brain Injured Patients Studied with 18FDG PET: A Descriptor of Brain Damage and a Possible Predictor of Outcome
, 4(2): 167 - 175Andrea Lupi, Giannettore Bertagnoni, Anna Borghero, Matteo Salgarello and Pierluigi Zanco
DOI: 10.2174/1874471011104020167
Editor-in-Chief
Andrea Ciarmiello
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia
(Italy)
Biography
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia
Biography
Biography of Andrea Ciarmiello
Andrea Ciarmiello graduated from the Universitá Federico II Medical School (Napoli, ITALY) in 1983. He was trained in Nuclear Medicine at Molinette University (Torino, ITALY) obtaining a Specialist Degree in 1987. Then followed by training in Diagnostic Radiology at Seconda Università di Napoli completed in 2001. His main research interests are in oncology and neurology and in the last years he worked on novel deep learning model and radiomic applied to molecular images. From 2009 to 2012 and from 2018 to date he is the head of the Diagnostic Imaging Department of S. Andrea Hospital.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Radiopharmaceuticals was launched in 2008 with the assistance of Dr. Sean L. Kitson who served as the Editor-in-Chief of the journal till 2021. The current Editor-in-Chief, Prof. Dr. Andrea Ciarmiello, took charge of the journal from June 2021.
Webmaster Contact: info@benthamscience.net